562 related articles for article (PubMed ID: 36869790)
1. Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy.
Vella V; Lappano R; Bonavita E; Maggiolini M; Clarke RB; Belfiore A; De Francesco EM
Endocr Rev; 2023 Jul; 44(4):693-723. PubMed ID: 36869790
[TBL] [Abstract][Full Text] [Related]
2. Receptor for the Advanced Glycation End Products (
Gutowska K; Czajkowski K; Kuryłowicz A
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446161
[TBL] [Abstract][Full Text] [Related]
3. Glycation & the RAGE axis: targeting signal transduction through DIAPH1.
Shekhtman A; Ramasamy R; Schmidt AM
Expert Rev Proteomics; 2017 Feb; 14(2):147-156. PubMed ID: 27967251
[TBL] [Abstract][Full Text] [Related]
4. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
Khalid M; Petroianu G; Adem A
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
[TBL] [Abstract][Full Text] [Related]
5. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
[TBL] [Abstract][Full Text] [Related]
6. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.
Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S
Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on signaling for biological- and processed food-related advanced glycation end-products and its role in cancer progression.
Eva TA; Barua N; Chowdhury MM; Yeasmin S; Rakib A; Islam MR; Emran TB; Simal-Gandara J
Crit Rev Food Sci Nutr; 2022; 62(10):2655-2672. PubMed ID: 33307763
[TBL] [Abstract][Full Text] [Related]
9. The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease.
Arivazhagan L; Popp CJ; Ruiz HH; Wilson RA; Manigrasso MB; Shekhtman A; Ramasamy R; Sevick MA; Schmidt AM
Cardiovasc Res; 2024 Feb; 119(18):2813-2824. PubMed ID: 36448548
[TBL] [Abstract][Full Text] [Related]
10. The RAGE/multiligand axis: a new actor in tumor biology.
Rojas A; Schneider I; Lindner C; Gonzalez I; Morales MA
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35727208
[TBL] [Abstract][Full Text] [Related]
11. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
Pertynska-Marczewska M; Merhi Z
Reprod Sci; 2015 Jul; 22(7):774-82. PubMed ID: 25228634
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products and insulin resistance.
Unoki H; Yamagishi S
Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
[TBL] [Abstract][Full Text] [Related]
13. RAGE and its ligands: from pathogenesis to therapeutics.
Jangde N; Ray R; Rai V
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):555-575. PubMed ID: 32933340
[TBL] [Abstract][Full Text] [Related]
14. Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.
Leerach N; Harashima A; Munesue S; Kimura K; Oshima Y; Goto H; Yamamoto H; Higashida H; Yamamoto Y
Glycoconj J; 2021 Jun; 38(3):303-310. PubMed ID: 33108607
[TBL] [Abstract][Full Text] [Related]
15. The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease.
Sharma A; Kaur S; Sarkar M; Sarin BC; Changotra H
Clin Rev Allergy Immunol; 2021 Apr; 60(2):244-258. PubMed ID: 33170477
[TBL] [Abstract][Full Text] [Related]
16. The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases.
Rojas A; Lindner C; Schneider I; Gonzalez I; Uribarri J
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672429
[TBL] [Abstract][Full Text] [Related]
17. RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review.
Faruqui T; Khan MS; Akhter Y; Khan S; Rafi Z; Saeed M; Han I; Choi EH; Yadav DK
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613714
[TBL] [Abstract][Full Text] [Related]
18. DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice.
Sotokawauchi A; Matsui T; Higashimoto Y; Nishino Y; Koga Y; Yagi M; Yamagishi SI
Diab Vasc Dis Res; 2021; 18(1):1479164121990533. PubMed ID: 33535822
[TBL] [Abstract][Full Text] [Related]
19. Molecular investigation of glycated insulin-induced insulin resistance via insulin signaling and AGE-RAGE axis.
Walke PB; Bansode SB; More NP; Chaurasiya AH; Joshi RS; Kulkarni MJ
Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166029. PubMed ID: 33248275
[TBL] [Abstract][Full Text] [Related]
20. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.
Pugazhenthi S; Qin L; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1037-1045. PubMed ID: 27156888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
